After the third month, the MPS dose was higher than that of MMF. There were no clinically important differences between the 2 groups, regarding other ...

It is noteworthy that systemic MPA exposure is higher with EC mycophenolate sodium than with mycophenolate mofetil, without increased gastrointestinal toxicity.

We compared the tolerability and efficacy of mycophenolate mofetil (MMF) versus mycophenolate sodium (MPS) among renal transplant recipients on tacrolimus- ...

We compared the tolerability and efficacy of mycophenolate mofetil (MMF) versus mycophenolate sodium (MPS) among renal transplant recipients on ...

The MPA ester, mycophenolate mofetil (MMF) is an effective component of anti-rejection therapy in solid-organ transplantation. Treatment with MMF is complicated ...

30 дек. 2022 г. · Pharmacokinetic and Pharmacodynamic Comparison of Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Maintenance Renal Transplant ...

13 нояб. 2018 г. · Globally, enteric-coated mycophenolate sodium (EC-MPS) is replacing mycophenolate mofetil (MMF) in maintenance immunosuppressant regimens.

We compared the tolerability and efficacy of mycophenolate mofetil (MMF) versus mycophenolate sodium (MPS) among renal transplant recipients on ...

21 июл. 2015 г. · Patients switched to EC-MPS experienced less gastrointestinal symptom burden and showed improvement in HRQoL.